TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Margit Schnee, PhD
Regulatory Affairs Manager CMC at Curevac AG

Profile

Dr. Margit Schnee is a biotechnologist by training with a PhD in virology (LMU, Munich, Germany). She started as a scientist in the prophylactic vaccine area at CureVac AG in 2007 developing RNA based vaccines and therapeutics. After some years she switched 2013 to Regulatory Affairs and more recently focussed on Regulatory Affairs CMC.

Margit Schnee, PhD's Network

Agenda Sessions

  • Regulatory View on mRNA Challenges in the Context of ATMP/Gene Therapy Guidelines

    , 18:00